These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10428529)

  • 41. Pelvic floor electrical stimulation in the treatment of stress incontinence: an investigational study and a placebo controlled double-blind trial.
    Yamanishi T; Yasuda K; Sakakibara R; Hattori T; Ito H; Murakami S
    J Urol; 1997 Dec; 158(6):2127-31. PubMed ID: 9366328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial.
    Stening KD; Eriksson O; Henriksson KG; Brynhildsen J; Lindh-Åstrand L; Berg G; Hammar M; Amandusson A; Blomqvist A
    Rheumatology (Oxford); 2011 Mar; 50(3):544-51. PubMed ID: 21078629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Climacteric vasomotor symptoms do not imply autonomic dysfunction.
    Virtanen I; Polo-Kantola P; Erkkola R; Polo O; Ekholm E
    Br J Obstet Gynaecol; 1999 Feb; 106(2):155-64. PubMed ID: 10426682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy.
    Karjalainen A; Heikkinen J; Savolainen MJ; Bäckström AC; Salinto M; Kesäniemi YA
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():38-43. PubMed ID: 9389782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.
    Winkler H; Jacoby K; Kalota S; Snyder J; Cline K; Robertson K; Kahan R; Green L; McCammon K; Rovner E; Rardin C
    Female Pelvic Med Reconstr Surg; 2018; 24(3):222-231. PubMed ID: 28953076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transvaginal radio frequency treatment of the endopelvic fascia: a prospective evaluation for the treatment of genuine stress urinary incontinence.
    Dmochowski RR; Avon M; Ross J; Cooper JM; Kaplan R; Love B; Kohli N; Albala D; Shingleton B
    J Urol; 2003 Mar; 169(3):1028-32. PubMed ID: 12576838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Krop IE; Mayer IA; Ganju V; Dickler M; Johnston S; Morales S; Yardley DA; Melichar B; Forero-Torres A; Lee SC; de Boer R; Petrakova K; Vallentin S; Perez EA; Piccart M; Ellis M; Winer E; Gendreau S; Derynck M; Lackner M; Levy G; Qiu J; He J; Schmid P
    Lancet Oncol; 2016 Jun; 17(6):811-821. PubMed ID: 27155741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of two global impression questionnaires for incontinence.
    Yalcin I; Bump RC
    Am J Obstet Gynecol; 2003 Jul; 189(1):98-101. PubMed ID: 12861145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial.
    Mikkelsen AL; Felding C; Clausen HV
    Gynecol Obstet Invest; 1995; 40(2):125-8. PubMed ID: 8575690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TVT Abbrevo and Miniarc suburethral sling in women with stress urinary incontinence - A randomised controlled trial.
    Melendez-Munoz J; Braverman M; Rosamilia A; Young N; Leitch A; Lee JK
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():141-146. PubMed ID: 30286363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women--a double-blind placebo-controlled study.
    Cardozo LD; Wise BG; Benness CJ
    J Obstet Gynaecol; 2001 Jul; 21(4):383-5. PubMed ID: 12521832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up.
    Khullar V; Cardozo LD; Abbott D; Anders K
    Br J Obstet Gynaecol; 1997 Jan; 104(1):96-9. PubMed ID: 8988705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women.
    Hassager C; Christiansen C
    Maturitas; 1988 Mar; 9(4):315-23. PubMed ID: 3288846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
    Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
    Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of urodynamic measures of urethral resistance with clinical measures of incontinence severity in women with pure genuine stress incontinence. The Continence Program for Women Research Group.
    Theofrastous JP; Bump RC; Elser DM; Wyman JF; McClish DK
    Am J Obstet Gynecol; 1995 Aug; 173(2):407-12; discussion 412-4. PubMed ID: 7645615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen and urinary incontinence in women.
    Sultana CJ; Walters MD
    Maturitas; 1994 Dec; 20(2-3):129-38. PubMed ID: 7715464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective placebo controlled double blind randomised study to investigate the use of indoramin to prevent post-operative voiding disorders after surgical treatment for genuine stress incontinence.
    Watson AJ; Currie I; Jarvis GJ
    Br J Obstet Gynaecol; 1999 Mar; 106(3):270-2. PubMed ID: 10426648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oestriol in the treatment of postmenopausal urgency: a multicentre study.
    Cardozo L; Rekers H; Tapp A; Barnick C; Shepherd A; Schussler B; Kerr-Wilson R; van Geelan J; Barlebo H; Walter S
    Maturitas; 1993 Dec; 18(1):47-53. PubMed ID: 8107615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.